Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,766 public trials 829 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19

NCT04418206

Conditions: COVID 19, COVID-19, Coronaviridae Infections, +10 more
Locations: CH Antibes Antibes, Alpes Maritimes, France

Ch Cannes, Pneumologie Cannes, Alpes Maritimes, France

Ch Grasse Grasse, Alpes Maritimes, France

CHU de nice Nice, Alpes-Maritimes, France

View Trial Details

Completed

Blood Product Supply

NCT07490314

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Methodist Dallas Medical Center- Clinical Research Institute Dallas, Texas, United States

View Trial Details

Completed

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

NCT05265065

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: District Health Centre Ulaanbaatar, Mongolia

View Trial Details

Completed

COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose

NCT05392075

Conditions: COVID-19, COVID-19 Pneumonia, Coronaviridae Infections, +10 more
Locations: Methodist Dallas Medical Center Dallas, Texas, United States

View Trial Details

Completed

Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults

NCT06585891

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

NCT04561193

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Methodist Dallas Medical Center Dallas, Texas, United States

View Trial Details

Completed

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly

NCT05283902

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: Valéria Valim Vitória, Espírito Santo, Brazil

View Trial Details

Completed

LetSync: Pilot Test of Mobile Health (mHealth) Intervention

NCT04951544

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever

NCT06684431

Conditions: Arbovirus Infections, Bunyaviridae Infections, Crimean Congo Hemorrhagic Fever, +7 more
Locations: Phase I Unit, Karolinska University Hospital Stockholm, Stockholm County, Sweden

View Trial Details

Completed

suPAR Michigan M2C2 Heterogeneity Validation Cohort Study

NCT07466524

Conditions: Acute Respiratory Distress Syndrome, COVID-19, Coronaviridae Infections, +14 more
Locations: Michigan state university, Department of Biostatistics Ann Arbor, Michigan, United States

View Trial Details

RNA Virus Infections

RNA Virus Infections trial results

Related conditions